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A B S T R A C T 5
The aim of this study was to determine the efficacy and surgical outcome of the sling procedures in stress incontinent
women in comparison to conventional anterior colporrhaphy. Total of 56 patients with stress urinary incontinence (SUI)
were treated with sling procedure between November 2011 and March 2013, 39/56 (69.6%) with suprapubic arc (SPARC)
and 17/56 (30.4%) with MiniArc method. During the same period total of 49 patients with SUI were treated with tradi-
tional anterior colporrhaphy according to Bagovi} method as the control group. All patients were prospectively clinically
assessed over a period of 3, 6 and 12 months after surgery. The objective cure rate after the follow-up was 92.9% (52/56) in
observed group of patients and 79.6% (39/49) in control group and improvement was occurred in rest of 5.4% (3/56) and
18.4% (9/49), respectively (p<0.05). The overall complications rate was significantly lower in the observed group of pa-
tients than in the control group, 12.5% (7/56) vs. 28.6% (14/49), (p<0.05). In the sling group was postoperatively noticed
slightly higher rate of urinary incontinence, but in the colporrhaphy group was emphasized rate of urinary retention.
Only one from the each group of patients failed the surgical procedure and required additional correction for SUI. The
mean operating time for SPARC and MiniArc procedure was 19±7 and 9±5 minutes, respectively (p<0.0001). Mean du-
ration of hospitalization was significantly shorter in the sling group of patients (2.6±1.0, range 2–7) days than in the
control group of (9.6±1.8, range 6–18), (p<0.001<0.0001). According to presented results, sling is a highly effective
method in patients with SUI with low incidence of perioperative complications, promising long-term results and high
patient’s satisfaction.
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Introduction
According to International Continence Society (ICS)
definition, Stress urinary incontinence (SUI) is involun-
tary discharge of urine caused by the congenital or ac-
quired defect of pelvic organs static with loss of vesicou-
rethral anatomic support1. Stress urinary incontinence is
clinically recognized as urethral hypermobility and in-
trinsic sphincter deficiency (ISSD). Hypermobility indi-
cates a significant change in position of the urethra and
bladder neck during the act of micturition. It is caused by
insufficient support of the bladder and urethrovesical
junction due to rupture of the pubocervical fascia. ISSD
is a condition in which the urethral sphincter is unable to
achieve sufficient tone which could overcome the intra-
vesical pressure, especially during the filling of the
bladder. It is caused by insufficient closure mechanism of
the urethra2–4. The diagnosis of stress urinary inconti-
nence can be set by the history, because patients referred
incontinence on some physical activity, e.g. sneezing,
coughing, running load lifting etc., which significantly
reduces their quality of life and ability to work5.
Many studies have shown an increased prevalence of
urinary incontinence with advancing age. Urinary incon-
tinence is estimated to affect up to 35% of adult women
and up to 50% of elderly women leading to deterioration
1063
Received for publication June 22, 2014
in quality of life of those affected6. The severity of uri-
nary incontinence also increases with age. This may be
explained by the interplay of multiple factors during the
aging process, including increasing medical comorbidi-
ties, medications use, impaired mobility and menopause.
Low estrogen production after menopause results in at-
rophy of the urethral epithelium with subsequent atro-
phic urethritis and cystitis that can predispose to the de-
velopment urinary incontinence. Increasing number of
vaginal deliveries and higher birth weight of newborns
are important risk factors for obstetrical pelvic floor inju-
ries connected to pelvic organ prolapse and urinary in-
continence. Obesity is risk factor for urinary inconti-
nence, and higher Body Mass Index (BMI) is associated
with an increased severity of urinary incontinence5,7.
Urinary incontinence is an important public health
problem with great impact on physical and mental health
of women. Treatment success depends on a diagnostic
procedure and a properly chosen therapy method. The
treatment of urinary incontinence can be performed by
surgical and conservative methods. Currently, there are
more than one hundred surgical methods to treat stress
urinary incontinence, which indicating that there are dif-
ferences in the understanding of its etiopathogenesis and
in the principles of surgical treatment for those patients.
Such a large number of proposed procedures, which are
performed in daily routine and the results of which are
often difficult to compare and are differently presented,
obviously prove that there are differences in their effi-
cacy5,8,9. A current trend in surgical therapy for stress
urinary incontinence is the application of simple, effec-
tive and safe laparoscopic surgery and sling methods
(SPARC, MiniArc)10,11.
Stress urinary incontinence is a prevalent problem for
which surgical treatment with a vaginal sling provides
an effective solution with low complication rates12. These
methods significantly reduce hospitalization and therapy
expenses, with earlier restoration of working ability. Lo-
cal tissue impairment and intervention is minimal which
decreases postoperative complications and provides for
restoration of the normal function7.
Over the past decade there have been several ad-
vancements for the treatment of stress urinary inconti-
nence in females13. The treatment of stress urinary in-
continence has been revolutionized by the introduction
of the tension-free vaginal tape (TVT)12,14,15. Since then,
many new slings with several modifications of the tech-
nique have seen the light and are currently used in clini-
cal practice. The midurethral tension-free vaginal tape
sling has emerged as the gold standard to treat female
stress urinary incontinence. The transobturator approach
was then developed to reduce risks of retropubic needle
passage. After the introduction of transobturator route,
the new trend now seems to be the mini-sling which uses
a single incision approach. Validation of these rapidly
evolving techniques is an absolute necessity12,16,17.
The retropubic (TVT) and transobturator (TOT) min-
imally invasive slings are effective and relatively safe
with cure rates of between 80 and 90%. However, there
are inherent risks associated with the external needle
passes through the abdomen or the groin6. The suprapu-
bic arc (SPARC) polypropylene midurethral tape is con-
sidered as one of the best surgical treatment methods for
women with stress urinary incontinence. The reported
success rate of the pubovaginal sling procedures using
various materials fluctuated impressively from 80–95%.
Until recently, the procedure has been reserved for pa-
tients who previously failed other surgical treatments,
but nowadays the indications are extended and the treat-
ment is widely applied in all types of stress urinary
incontinence18.
Obesity is considered not only a risk factor for stress
urinary incontinence, but there is also a concern about a
higher failure rate for SUI procedures19. Most recently,
the mini-sling has been developed in attempts to place
the sling without any needle passages through the abdo-
men or groin14. The concept of mini-slings was to elimi-
nate foreign material, easing the procedure to be carried
out under local anesthesia with achieving the same effi-
cacy as previous generations of tension free vaginal ta-
pes. The single incision MiniArc sling is a novel even less
invasive, easier to handle and more swiftly sling proce-
dure9. MiniArc procedure was developed to limit the
number of incisions and reduce the risks of blind needle
passes through the groin or abdomen, while mimicking
the position and results of the TOT sling. Over recent
years their use has been increasing worldwide as numer-
ous observational cohort studies have shown minimal
complications, quick recovery and 1-year efficacy within
the range 85–94%6,12,14,16.
The sling operation using polypropylene tape in pa-
tients with stress urinary incontinence is a minimally in-
vasive method with a rare postoperative complications
and shorter hospitalization compared with conventional
surgery. The sling method allows a successful anatomical
and functional reconstruction of the anterior vaginal
wall defects and significantly improves the quality of
life11,15,18. We have done a prospective study to assess ob-
jective and subjective outcome of a minimal invasive
sling procedures in treatment of female stress urinary in-
continence compared with the established conservative
surgery.
Patients and Methods
This prospective study included a total number of 105
patients surgically treated for stress urinary inconti-
nence. In the period between September 2011 and March
2013 a total of 56 patients with SUI were treated with
sling procedure, 39/56 (69.6%) with suprapubic arc (SPARC)
and 17/56 (30.4%) with MiniArc method. During the
same period a total of 49 patients with SUI were treated
with traditional anterior colporrhaphy as the control
group.
All of patients were preoperatively assessed by physi-
cal examination and urodynamic study. Defects of the an-
terior vaginal wall was estimated according to the Pelvic
Organ Prolapse Quantification (POP-Q) system and all
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types of other vaginal support defects such as cystocele,
rectocele or uterine prolapse were excluded from the
study20. All patients filled in two customized question-
naires, Pelvic Floor Distress Inventory (PFDI-20) and
Pelvic Floor Impact Questionnaire (PFIQ-7) which in-
cludes questions about the quality of life until the past 3
months before operation21,22.
The collection of clinical data and the responses from
the questionnaires prospectively continued 3, 6 and 12
months after surgery, and also recorded any periope-
rative or later complications. Patients were followed for
persistent urinary leakage, urgency and retention. Sta-
tistical analysis was performed. Clinical success was de-
fined as complete resolution of stress urinary inconti-
nence requiring no further treatment.
Surgical methods
SPARC procedure (American Medical Systems, Min-
netonka, MN, USA) was performed positioning the poly-
propylene tape under the midurethra into the subcuta-
neous tunnel which passes at the posterior wall of the
symphisis through the endopelvic fascia without fixa-
tion. Following intraoperative cystoscopy after intrave-
sical instillation of 250 mL 0.9% saline solution has done
to check for potential bladder injury. During the bladder
was full, the optimal tension of the tape was achieved by
the slightly simultaneous traction with scissors placed
between tape and midurethra to avoid postoperative re-
tention. Finally, continence was checked by the patients
coughing or abdominal wall compression above the sym-
phisis, depending of patient’s compliance and type of the
anesthesia. Tension was considered sufficient if no sig-
nificant urine leaking obtained during the provocation
test11,18. A Foley catheter routinely stayed inserted in the
bladder until a day after surgery.
MiniArc sling (American Medical Systems, Minneton-
ka, MN, USA) was performed as original procedure plac-
ing the short polypropylene tension-free tape under the
midurethra through the small suburethral vaginal inci-
sion and bilateral fixation into the internal obturatory
muscle following minimal periurethral dissection. The
vaginal epithelium was dissected off the underlying sub-
urethral tissues out to the pelvic sidewall, adjacent to the
posterior surface of the ischiopubic ramus. The tunnel
that is created should be only large enough to ensure the
tape lies flat under the urethra. The sling/needle assem-
bly is then placed into the dissected tunnel and directed
towards the obturator space into the obturator internus
muscle. The needle is then easily removed by simply slid-
ing it back out of the fixating tip. The needle is then
placed into the other self-fixating tip, and the sling is in-
troduced into the contralateral side. The needle is slowly
advanced into the obturator internus muscle until a ten-
sion-free adjustment is completed under the midurethra.
The vaginal epithelium is then closed with absorbable
sutures11,23. A Foley catheter routinely stayed inserted in
the bladder until a day after surgery.
Conventional anterior colporrhaphy was performed
according to Bagovi} method of the urethral plication.
The patient initially was placed in a high-dorsal lithoto-
mic position with the perineum at the end of the operat-
ing table for surgical exposure. The bladder was emptied
and a weighted speculum was inserted into the vagina.
After the sagital incision of anterior vaginal wall the vag-
inal mucosa was grasped at its cranial border with two
clamps. The mucosa was freed laterally from its underly-
ing adherent fascia. A series of vertical mattress sutures
were placed in the mobilized paraurethral and paravesi-
cal fascia to reduce the cystourethrocele and elevate the
posterior urethra to a high-retropubic position. The sub-
urethral placement of nonabsorbable X-suture to achieve
bladder neck elevation and functional urethral elonga-
tion was the leading moment for correction SUI. The re-
dundant mucosa was excised and the edges were reap-
proximated and excision margins were closed with
absorbable sutures. A Foley catheter was often inserted
at the end of the surgery to prevent bladder overdisten-
tion and routinely removed on sixth day after surgery5,24.
All procedures were completed under general or re-
gional/local anesthesia as determined by the surgeon and
anesthesiologist.
Outcome evaluation
The incidence of perioperative and later postoperative
complications such as urinary retention, urgency, incon-
tinence and infection were observed, as well as the other
milder difficulties like transitory pain. Urinary retention
was identified as residual urine >50 mL after spontane-
ous micturition. Urgency and incontinence was consid-
ered if persisted >4 weeks after the operation. Urinary
infection was recognized by the clinical signs and verified
by the microbiological urine analysis. Operating time
and hospitalization period were also noticed in both
groups of patients.
Objective operation outcome was evaluated from the
patient’s symptoms, urogynecologic inspection and uro-
dynamic estimation at postoperative check-up controls.
Subjective patient’s satisfaction was assessed by the cus-
tomized questionnaires regarding the general health
condition, eventual consequent difficulties and postoper-
ative improvement of quality of life including sexual ac-
tivities. Surgical outcome was defined as completely cured,
partial improved and failed. Completely cured patients
had no any lover urinary system symptoms, partial im-
proved were patents with very mild urinary voiding diffi-
culties and surgery failed in patients with moderate to
severe postoperative SUI.
Statistics
Statistical analysis included c2-test and Student’s
t-test. Probabilities lower than 5% (p<0.05) were recog-
nized statistically significant. Statistics was performed
with Statistical Package for Social Sciences, version
13.0 (SPSS Inc., Chicago, IL, USA) and Microsoft Excel,
version 11.0 (Microsoft Corporation, Redmond, WA,
USA).
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Results
The study included a total of 105 patients with SUI,
56/105 (53.3%) treated by the sling method and 49/56
(46.7%) treated by the conventional surgery. There was
no significant difference in the mean age (54.6±11.6 vs.
58.8±12.7) and parity (2.1±0.9 vs. 2.1±0.8) between the
sling operation patients and traditional anterior colporr-
haphy group (Tables 1–3).
In the sling group of patients, there was a slightly
higher proportion of childbearing and perimenopausal
women, 29/56 (51.8%) vs. 17/49 (34.7%), in the colporr-
haphy group, but not significantly (c2=3.10, p=n.s., Ta-
ble 4).
Of the total 56 patients in the sling group, SPARC
procedure was performed in 39 (69.6%) patients and
MiniArc procedure in the rest of 17 (30.4%) patients. The
mean operating time for SPARC and MiniArc procedure
was 19±7 and 9±5 minutes, respectively (p<0.0001). In
all 49 patients of the control group were performed con-
ventional anterior colporrhaphy according to Bagovi}
method. Mean duration of hospitalization was 2.6±1.0
(range 2–7) days in the observed group and 9.6±1.8
(range 6–18) days in the control group of patients (c2=
82.66, p<0.001, t-test=25.30, p<0.0001, Table 5).
In 29/56 (51.6%) patients of the observed group sling
procedure was the first operation, as well as colporr-
haphy in 28/49 (57.1%) patients of the control group. The
remaining 27 (48.4%) patients in the observed group and
21 (42.9%) in the control group had undergone the abdo-
mino-pelvic operation previously (c2=0.03, p=n.s., Table
6).
A total of 42 previous operations were done in the
sling group of patients and 26 in the control group. In the
sling group of patients there was a slightly higher pro-
portion of previous vaginal hysterectomy 5/56 (8.9%), an-
terior colporrhapy 5/56 (8.9%), cervical conisation or am-
putation 4/56 (7.1%) and sling 4 (7.1%) or mesh 7/56
(12.5%) procedure than in the control group, but not sig-
nificant (c2=3.95, p=n.s., Table 7).
The overall complications rate after the follow-up was
12.5% (7/56) in observed group of patients and 28.6%
(14/49) in control group (c2=4.22, p<0.05). In one pa-
tient from colporrhaphy group was occurred persistent
perioperative hemorrhage which required surgical revi-
sion 3 hours after the operation. In the sling group was
postoperatively noticed slightly higher rate of urinary in-
continence, but in the colporrhaphy group was empha-
sized rate of urinary retention. All of those patients man-
aged conservatively, without voiding difficulties on con-
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TABLE 1
AGE AND PARITY MEAN VALUES
Age Parity
Sling Colporrhaphy Sling Colporrhaphy
X±SD 54.6±11.6 58.8±12.7 2.1±0.9 2.1±0.8
Range 24–82 30–81 0–5 0–4
TABLE 2
AGE DISTRIBUTION OF THE PATIENTS
Age Sling (N) % Colporrhaphy (N) %
<45 12 21.4 8 16.3
46–55 17 30.4 9 18.4
56–65 18 32.1 17 34.7
>65 9 16.1 15 30.6
Total 56 100.0 49 100.0
c2=4.34, p=0.227, t-test=1.77, p=0.080
TABLE 3
PARITY DISTRIBUTION OF THE PATIENTS
Parity Sling (N) % Colporrhaphy (N) %
1 13 23.2 10 20.4
2 33 58.9 28 57.1
>3 10 17.9 11 22.4
Total 56 100.0 49 100.0
c2=0.38, p=0.825, t-test=0.35, p=0.731
TABLE 4
HORMONAL STATE DISTRIBUTION OF THE PATIENTS
Hormonal state Sling (N) %
Colporr-
haphy (N)
%
Generative age 12 21.4 8 16.3
Perimenopause 17 30.4 9 18.4
Postmenopause 27 48.2 32 65.3
Total 56 100.0 49 100.0
c2=3.10, p=0.078
TABLE 5
DURATION OF THE HOSPITALIZATION
Hospitaliza-
tion days
Sling (N) % Colporrhaphy (N) %
<7 55 98.2 5 10.2
>7 1 1.8 44 89.8
Total 56 100.0 49 100.0
c2=82.66, p<0.001, t-test=25.30, p<0.0001
TABLE 6
FREQUENCY OF THE PREVIOUS SURGERY
Previous
surgery
Sling (N) % Colporrhaphy (N) %
1 19 33.9 18 36.7
2 4 7.1 2 4.1
>3 4 7.1 1 2.0
c2=1.33, p=0.515
trol visits. There was no significant difference in the
overall complications rate in the both groups of patients
between those ones with and without previous surgery
(Table 8).
The objective cure rate after the follow-up was 92.9%
(52/56) in observed group of patients and 79.6% (39/49)
in control group and improvement was occurred in rest
of 5.4% (3/56) and 18.4% (9/49), respectively (c2=3.98,
p<0.05). Only one from the each group of patients failed
the surgical procedure and required additional correc-
tion for SUI (Table 9).
No major intraoperative or seriously immediate post-
operative complications were observed in the sling group
of patients and no bladder injury was occurred during
routine post-op cystoscopy. No vascular damage or signif-
icant bleeding was noticed in this group of patients and
there was no alteration between preoperative and post-
operative red blood cell count. After removal of Foley
catheter 54/56 (96.4%) patients of the sling group could
void volitionally with no residual urine. None of those pa-
tients required releasing of sling tension because of uri-
nary retention and no permanent voiding difficulties or
strain to void noticed on routine check-up controls. Other
milder complications like transitory episodes of pain, uri-
nary urgency, polakisuria and nocturia were infrequent
and not statistically significant.
Discussion and Conclusion
Minimally invasive operations for SUI are nowadays
most desirable and justified methods, not only for medi-
cal reasons but also for social and economic reasons.
Those procedures are quick, low risk and minimally inva-
sive operations in which the genital organs are not extir-
pated. This means that the patient’s body integrity is
preserved, which is exceptionally important not only for
medical and psychological reasons but for reproductive
and sex life reasons as well10,12.
Regional/local anesthesia considerably reduces the risk
of anesthesiologic complications, including fatality. In ad-
dition, the ability to communicate with the patient dur-
ing the operation leads to maximal cooperation in each
phase of the operation, especially during the traction of
the polypropylene tape when the patients can contract
the abdominal wall themselves (by coughing instead of
Valsalva maneuver), enabling the surgeon to check the
effect of the correction. It is obvious that regional/local
anesthesia requires careful selection of physiological
well-prepared patients for the sling procedures15,25.
Quick mobilization of the patient along with sponta-
neous voiding without prolonged catheterization and
prophylactic antibiotics decreases the risk of postopera-
tive complications (thromboembolic disease, urinary in-
fection). The short hospital stay, faster rehabilitation and
short sick-leave obviously represent a number of advan-
tages, social, medical and economic. Relatively high cost
price of polypropylene tape is compensated with savings
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TABLE 7
PREVIOUS SURGERY
Previous surgery Sling (N) % Colporrhaphy (N) %
Abdominal hysterectomy 6 10.7 6 12.2
Adnexectomy/Salpingectomy 3 5.4 5 10.2
Vaginal hysterectomy 5 8.9 2 4.1
Anterior colporrhaphy 5 8.9 2 4.1
Cervical conisation/amputation 4 7.1 2 4.1
Sling 4 7.1 – –
Mesh 7 12.5 – –
Appendectomy 2 3.6 4 8.2
Other 6 10.7 5 10.2
c2=3.95, p=0.413
TABLE 8
INCIDENCE OF COMPLICATIONS
Complications Sling (N) %
Colporr-
haphy (N)
%
Retention 2 3.6 6 12.2
Urgency 1 1.8 2 4.1
Incontinence 4 7.1 2 4.1
Hemorrhage – – 1 2.0
Urinary infection – – 3 6.1
c2=4.22, p=0.040
TABLE 9
SURGICAL OUTCOME
Outcome Sling (N) % Colporrhaphy (N) %
Cured 52 92.9 39 79.6
Improved 3 5.4 9 18.4
Failed 1 1.8 1 2.0
Total 56 100.0 49 100.0
c2=3.98, p=0.046
achieved at all other levels of surgical treatment by sling
operation6,15.
Our study strongly confirmed these facts and objec-
tively contributed to the knowledge of the sling proce-
dures for SUI. All patients in our study were regularly
hospitalized for minimally invasive or conventional sur-
gery for genuine stress incontinence. Both groups of pa-
tients were approximately similar age and parity distri-
bution with a slightly higher proportion of postmeno-
pausal women in the control group, but not significantly.
Regarding the age, parity and hormonal state as a proven
risk factors of SUI it was easy to explain that structure of
our patients. Relatively higher share of posmenopausal
patients in the control group was associated with some-
thing more frequent choice of conventional anterior col-
porrhaphy in these patients, particularly those without
previous surgery correction of SUI. Comparing the con-
trol group, it was obvious that the group of sling patients
recorded higher number of previous vaginal surgery such
as vaginal hysterectomy, anterior colporrhapy, cervical
conisation or amputation and sling or mesh procedure.
Particularly those patients with previously performed
sling or mesh procedure were represented here by a
share of almost 20%.
Considering the recent reports on sling procedures
efficacy6,12,14,16, the objective cure rate after the follow-up
in our study was evidently high (92.6%) and in remaining
patients has been achieved satisfactory improvement.
Comparing to objective cure rate in colporrhaphy group
(79.6%), difference was statistically significant (p<0.05).
The mean operating time for SPARC and MiniArc proce-
dure was <20 and <10 minutes, respectively (p<0.0001),
which correlates with recently published studies12,19.
Hospitalization period was also significantly shorter in
observed group than in control group (p<0.001<0.0001),
which gives more advantage to the minimal invasive
sling procedure.
Overall complications rate was significantly lower in
the sling group than in colporrhaphy group (p<0.05).
Perioperatively was recorded 3/7 complications in the
sling group and 10/14 complications in the colporrhaphy
group. Higher incidence of perioperative urinary reten-
tion occurred in this group comparing to the sling group
(6 vs. 2) was probably related to the duration and techni-
cal characteristics of open surgery approach. The rest of
four complications in each group of patients were oc-
curred postoperatively. In the sling group were observed
four patients with incontinence from 3 to 6 months after
surgery, and in the control group a total of four patients
with various complications from 3 to 12 months after
surgery.
According to presented results, neither perioperative
bladder injury nor seriously urinary retention was oc-
curred in our study. All cases of urinary retention man-
aged conservatively without further voiding difficulties,
usually reported by previous investigations. Vascular,
bowel or nerve injury reported previously, have also not
been detected. The anatomical and functional recon-
struction of anterior vaginal wall was achieved in all pa-
tients. No infection, erosion or defective healing of the
vaginal wall was observed. There were no alterations be-
tween preoperative and postoperative blood cell count
except in one patient from colporrhaphy group with per-
sistent perioperative hemorrhage and surgical revision.
Postoperative urgency and incontinence in both group
of patients was caused by the various and different rea-
sons, i.e. age, hormonal state, mechanic irritation, ner-
vous and myogcenic detrusor instability etc. In the sling
group 3/4 patients with postoperative incontinence were
previously undergone to urogynecological surgery (vagi-
nal hysterectomy with anterior colporrhaphy, PERI-
GEE) which corresponding to published reports15,18. One
patient from the sling group had previously SPARC and
MiniArc procedure and was undergone to conservative
treatment by the urethral injection of dextranomere/
hyaluronic acid copolymer (Urodex)26. The other patient
from the colporrhaphy group was successfully undergone
to additional SPARC procedure. Rest of the patients was
managed successfully treated with medications, i.e. mus-
carinic M3-selective receptor antagonist (solifenacin) and
b3-adrenergic receptor agonist (mirabegron) in accor-
dance with current guidelines27–29. Some of those pa-
tients were also additionally undergone to the extracor-
poreal magnetic innervation (ExMI) treatment30.
Urinary infection was observed in 3/4 patients with
some complications from the colporrhaphy group and no
one in the sling group, which was probably related to the
surgical approach, duration of surgery and a longer pe-
riod of bladder catheterization. All patients successfully
treated with antibiotics considering to microbiological
analysis of urine.
In all sling group patients has been noticed normal
vaginal healing. We observed no rejection or exposure of
the sling tape and subjectively none of patients com-
plained on later prolapse symptoms. Patient’s satisfac-
tion and the favorable surgical outcome were generally
achieved including sex life improvement.
In our study the sling procedure showed significantly
higher objective cure rate and lower overall rate of com-
plications with shorter operation time and hospitaliza-
tion period in comparison to conventional anterior col-
porrhaphy. We consider the sling procedure as highly
efficacious and safe minimally invasive and body integ-
rity preserving method with remarkably low rate of com-
plications.
The sling procedures has objectively become the gold
standard in patients with genuine or mixed SUI, in
whom there is no need of an operation of the uterus
or/and adnexa, as well as in patients who have previously
undergone unsuccessful SUI correction, including a pos-
sible previous sling operation. In patients with SUI, espe-
cially without preceding vaginal operations, sling methods
promising successful long-term results and high patient
satisfaction.
Our experience strongly supports initial favorable im-
pressions of recent published studies, so we intend to
evaluate wider aspects and perspectives of this proce-
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dure. Moreover, we expect further results of this study to
properly confirm the specific impact of the sling opera-
tion on the quality of life in patients with SUI compared
with patients operated by conventional surgery.
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U^INKOVITOST SLING POSTUPAKA U LIJE^ENJU @ENA SA
STATI^KOM INKONTINENCIJOM URINA
S A @ E T A K
Cilj ovog istra`ivanja bilo je utvrditi u~inkovitost i operacijski ishod sling postupaka u `ena sa stati~kom inkontinen-
cijom urina (SIU) u poredbi sa konvencionalnom prednjom kolporafijom. U razdoblju od studenog 2011. do o`ujka 2013.
sling postupcima lije~eno je ukupno 56 bolesnica sa SIU, 39/56 (69,6%) metodom SPARC i 17/56 (30,4%) metodom
MiniArc. Tijekom istog razdoblja ukupno je 49 bolesnica sa SIU operirano primjenom klasi~ne prednje kolporafije me-
todom po Bagovi}u kao poredbena skupina. Sve bolesnice prospektivno su klini~ki nadzirane u razdoblju od 3, 6 i 12
mjesec nakon operacije. Ukupna stopa izlje~enja nakon razdoblja klini~kog nadzora iznosila je 92,9% (52/56) u proma-
tranoj skupini bolesnica i 79,6% (39/49) u poredbenoj skupini, a do pobolj{anja je do{lo u ostalih 5,4% (3/56) bolesnica u
promatranoj i 18,4% (9/49) bolesnica u poredbenoj skupini (p<0,05). Ukupna stopa komplikacija bila je zna~ajno ni`a u
promatranoj skupini bolesnica nego u poredbenoj skupini, 12,5% (7/56) naspram 28,6% (14/49), (p<0,05). U skupini
bolesnica lije~enih sling metodama poslijeopreacijski je zabilje`ena ne{to vi{a stopa inkontinencije, a u skupini klasi~no
operiranih bolesnica ne{to izra`enija stopa urinarne retencije. Kirur{ko lije~enje nije uspjelo u samo po jedne bolesnice
iz svake skupine i bilo je potrebno u~initi dodatnu korekciju SIU. Prosje~no trajanje operacije iznosilo je 19±7 minuta
za SPARC, a 9±5 minuta za MiniArc, (p<0,0001). Prosje~no trajanje bolni~kog lije~enja bilo je zna~ajno kra}e u skupini
bolesnica lije~enih sling postupkom (2,6±1,0, raspon 2–7) dana nego u poredbenoj skupinu (9,6±1,8, raspon 6–18),
(p<0,001<0,0001). Slijedom prikazanih rezultata, sling metode su vrlo u~inkovite u lije~enja SIU sa niskom pojavno{}u
perioperacijskih komplikacija i obe}avaju}im dugoro~nim rezultatima te primjerenim zadovoljstvom bolesnica.
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